Imaging activated T cells predicts response to cancer vaccines. The Journal of Clinical Investigation.Volume 128, Number 6, June 2018. Read more.
Assessment of pharmacology and toxicology of anti-CTLA-4 antibody (ADU-1604) in non-human primates and evaluation of local anti-CTLA-4 application. Aduro Biotech Europe, Oss, The Netherlands; and Aduro Biotech, Berkeley, CA, USA. Poster #1702, 2018. Read more.
Extremely stable high molecular mass soluble multiprotein complex from eggs of sea urchin Strongylocentrotus intermedius with phosphatase activity. Wiley, Journal of Molecular Recognition. 2018;e2753. Read more.
Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. PLOS ONE. Navas, T. et al, 13 (6). 2018. Read more.
Using MALDI-TOF MS coupled with a high-mass detector to directly analyze intact proteins in thyroid tissues. Sci China Chemistry. Wang, S. et al, Volume 22, Issue 193, May 2018 Read more.
Binding Specificities of Nanobody•Membrane Protein Complexes Obtained from Chemical Cross-Linking and High-Mass MALDI Mass Spectrometry. American Chemical Society. Kohler, S. et al, Volume 90, Issue 8, p5306-5313. March 2018 Read more.
TREM-1 multimerization is essential for its activation on monocytes and neutrophils. Cellular & Molecular Immunology. Kevin, C.et al., March 2018, Read more.
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. Cancer Cell. Li, CW. et al., Volume 33, Issue 2, p187-201.e10, February 2018, Read more.
How human IgGs against myelin basic protein (MBP) recognize oligopeptides and MBP. Journal of Molecular Recognition. Belov, S. et al., Volume 30, Issue 10, October 2017, more.